SCHEMBL2870355

SCHEMBL2870355

N#Cc1cccc(C(=O)NCc2cc3c(-c4cccc(F)c4)n[nH]c3cc2F)c1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.50
CSNK1D P48730 1/20 0.47
TRPA1 O75762 1/20 0.46
ROCK2 O75116 1/20 0.45
CHRM3 P20309 2/20 0.44
MAP2K4 P45985 2/20 0.44
VNN1 O95497 1/20 0.44
LRRK2 Q5S007 1/20 0.43
TTK P33981 4/20 0.43
MAPK3 P27361 3/20 0.42
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
SNCA P37840 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863237 0.91 CSNK1D (0.52) MAPK1CSNK1DROCK2CHRM3MAP2K4
SCHEMBL2870225 0.89 NTRK1 (0.50) MAPK1CSNK1DTRPA1ROCK2CHRM3
SCHEMBL13635746 0.86 CSNK1D (0.49) MAPK1CSNK1DROCK2CHRM3MAP2K4
SCHEMBL2862635 0.85 DGAT2 (0.56) CSNK1DROCK2TTK
SCHEMBL2867437 0.84 CSNK1D (0.47) MAPK1CSNK1DMAP2K4MAPK3
SCHEMBL13198273 0.80 DGAT2 (0.50) MAPK1CSNK1DROCK2TTK
SCHEMBL2863001 0.79 NTRK1 (0.56) MAPK1CSNK1DROCK2MAP2K4TTK
SCHEMBL2872610 0.78 DGAT2 (0.56) MAPK1CSNK1DROCK2TTK
SCHEMBL2866831 0.75 CSNK1D (0.51) CSNK1DROCK2
SCHEMBL2870798 0.73 NTRK1 (0.52) MAPK1CSNK1DROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885CSNK1D 134/4885TRPA1 308/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPK1 1/4885CSNK1D 90/4885TRPA1 755/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885CSNK1D 134/4885TRPA1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.